- Filter by
- Categories
- Tags
- Authors
- Show all
- All
- Acute lymphoblastic leukemia (ALL)
- Acute myeloid leukemia (AML)
- Adolescent and young adult (AYA)
- Advocacy
- Bladder cancer
- Blood cancer
- Brain Cancer
- Breast cancer
- Cancer control
- Cancer screening
- Cancer surveillance
- Cancer treatment
- Care delivery
- Chemotherapy
- Chronic lymphocytic leukemia (CLL)
- Chronic myelogenous leukemia (CML)
- Clinical trial
- Colon Cancer
- Colorectal cancer
- ComboMATCH
- Data science
- Disparities
- Diversity
- Gallbladder cancer
- Gastric cancer
- Gene testing
- Genitourinary cancer
- Genomic testing
- Geriatric oncology
- GI cancer
- Glioblastoma
- Group meeting
- Head and neck cancer
- Health disparities
- Health equity
- Hogkin lymphoma
- Immunotherapy
- In memory
- Kidney cancer
- Leadership
- Leukemia
- Liver cancer
- Lung cancer
- Lymphoma
- Mammography
- Medical breakthrough
- Melanoma
- Mentorship
- Multiple myeloma
- Myelodysplastic syndrome (MDS)
- Myeloma
- Myeloproliferative neoplasms
- NCI-MATCH
- NCORP
- Non-Hodgkin lymphoma
- Pancreatic cancer
- Pancreatic cysts
- Patient-reported outcomes (PROs)
- Penis cancer
- Personalized screening
- Personalized treatment
- Precision medicine
- Precision oncology
- PrECOG
- Prevention
- Prostate cancer
- Quality of life
- Radiology
- Real world data
- Renal cell carcinoma
- Research results
- Sarcoma
- Sexual and gender minorities
- Skin cancer
- Smoking cessation
- Social determinants of health (SDoH)
- Stomach cancer
- Survivorship
- TAILORx
- Targeted therapy
- TMIST
- Travel scholarship
- Treatment trial
November 15, 2023
November 15, 2023
Categories
Do you like it?
July 20, 2023
July 20, 2023
Categories
Press Release: ECOG-ACRIN adds a new treatment trial to the ComboMATCH precision medicine initiative
Do you like it?
June 16, 2023
June 16, 2023
Categories
Do you like it?
June 1, 2023
May 17, 2023
May 17, 2023
Categories
Do you like it?
May 11, 2023
December 13, 2022
December 13, 2022
Categories
Do you like it?
December 11, 2022
December 6, 2022
December 6, 2022
Categories
Do you like it?